SMT201500005B - Composizione framaceutica inalabile - Google Patents

Composizione framaceutica inalabile

Info

Publication number
SMT201500005B
SMT201500005B SM201500005T SM201500005T SMT201500005B SM T201500005 B SMT201500005 B SM T201500005B SM 201500005 T SM201500005 T SM 201500005T SM 201500005 T SM201500005 T SM 201500005T SM T201500005 B SMT201500005 B SM T201500005B
Authority
SM
San Marino
Prior art keywords
pharmaceutical composition
inhalable pharmaceutical
inhalable
composition
pharmaceutical
Prior art date
Application number
SM201500005T
Other languages
English (en)
Inventor
Paul Michael Dorinsky
David Price
Original Assignee
Teva Branded Pharmaceutical Prod R & D Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43896828&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201500005(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Branded Pharmaceutical Prod R & D Inc filed Critical Teva Branded Pharmaceutical Prod R & D Inc
Publication of SMT201500005B publication Critical patent/SMT201500005B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
SM201500005T 2010-02-16 2015-01-08 Composizione framaceutica inalabile SMT201500005B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30499810P 2010-02-16 2010-02-16
PCT/EP2011/000692 WO2011101114A2 (en) 2010-02-16 2011-02-15 An inhalable pharmaceutical composition

Publications (1)

Publication Number Publication Date
SMT201500005B true SMT201500005B (it) 2015-05-05

Family

ID=43896828

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500005T SMT201500005B (it) 2010-02-16 2015-01-08 Composizione framaceutica inalabile

Country Status (11)

Country Link
US (1) US20110212137A1 (it)
EP (1) EP2536412B1 (it)
DK (1) DK2536412T3 (it)
ES (1) ES2527604T3 (it)
HR (1) HRP20141240T1 (it)
PL (1) PL2536412T3 (it)
PT (1) PT2536412E (it)
RS (1) RS53821B1 (it)
SI (1) SI2536412T1 (it)
SM (1) SMT201500005B (it)
WO (1) WO2011101114A2 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016118721A1 (en) * 2015-01-23 2016-07-28 Teva Branded Pharmaceutical Products R& D, Inc. An inhalable medicament
WO2018047013A1 (en) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same
WO2018047002A1 (en) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
WO2019171174A2 (en) 2018-03-07 2019-09-12 St Ip Holding Ag Combination compositions and therapies comprising 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, and methods of making and using same
EP3853223A1 (en) 2018-09-18 2021-07-28 ST IP Holding AG Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2- dithiole-3-thiones
WO2021186244A1 (en) 2020-03-16 2021-09-23 St Ip Holding Ag Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2-dithiole-3-thiones
US11135220B1 (en) 2020-04-08 2021-10-05 St Ip Holding Ag Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2006A (en) * 1841-03-16 Clamp for crimping leather
US2010A (en) * 1841-03-18 Machine foe
US2009A (en) * 1841-03-18 Improvement in machines for boring war-rockets
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers

Also Published As

Publication number Publication date
DK2536412T3 (en) 2015-01-19
WO2011101114A3 (en) 2012-04-19
WO2011101114A2 (en) 2011-08-25
ES2527604T3 (es) 2015-01-27
RS53821B1 (en) 2015-06-30
EP2536412B1 (en) 2014-11-12
US20110212137A1 (en) 2011-09-01
EP2536412A2 (en) 2012-12-26
PT2536412E (pt) 2015-02-04
PL2536412T3 (pl) 2015-07-31
HRP20141240T1 (en) 2015-03-13
SI2536412T1 (sl) 2015-05-29

Similar Documents

Publication Publication Date Title
SMT201700008B (it) Composizione farmaceutica
SMT201600350B (it) Composizioni farmaceutiche
CO6852076A2 (es) Composiciones farmacéuticas inhalables
DK3246018T3 (da) Farmaceutisk sammensætning
DK2694038T3 (da) Farmaceutisk sammensætning
DK3284467T3 (da) Nikotinholdige farmaceutiske sammensætninger
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
SMT201700050B (it) Composizioni anestetiche termogelificanti
BR112014003052A2 (pt) composições farmacêuticas
BR112013013026A2 (pt) inalador
DK2525798T3 (da) Anæstetisk formulering
CO6930367A2 (es) Composiciones farmaceúticas
EE201300005A (et) Ravimkoostis
GT201200303A (es) Formulaciones farmacéuticas
BR112013014644A2 (pt) composição farmacêutica e complexo
DK2654736T3 (da) Hidtil ukendt farmaceutisk sammensætning
CO6940426A2 (es) Formulaciones farmacéuticas
DK2815752T3 (da) Oral farmaceutisk sammensætning
DK2897594T3 (da) Farmaceutisk sammensætning
SMT201500005B (it) Composizione framaceutica inalabile
CO6801722A2 (es) Composiciones farmacéuticas
DK2542224T3 (da) Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
BR112013008074A2 (pt) combinações farmacêuticas
BR112014015885A2 (pt) preparação farmacêutica
BR112012027133A2 (pt) inalador